LabGenomics said it would participate in the Cancer Moonshot Initiative project, which aims to reduce the death rate from cancer by more than 50 percent over the next 25 years, pushed by the Joe Biden administration.LabGenomics stressed that it is the only Korean company offering cancer diagnostic s
A bill that defines digital healthcare and deals with information subjects and its utilization methods is drawing the industry’s attention.Rep. Shin Hyun-young of the opposition Democratic Party of Korea (DPK) recently proposed the “Act on the use of digital healthcare and health and medical data.”T
Daewoong Pharmaceutical said Thursday that its botulinum toxin product Nabota (Juveau in the U.S.) was patented as a neurotoxin composition for treating headaches through its U.S. partner, AEON Biopharma, with exclusive rights until 2041.The patent obtained from the U.S. Patent and Trademark Office
FutureChem said it has received the final report for the U.S. phase 1 clinical trial of FC705, a prostate cancer treatment candidate.The University of Maryland Medical Center and five other centers conducted the phase 1 trial in the U.S.According to the results, all participating patients who receiv
Lunit said it has signed a distribution agreement with Guardant Health, a U.S.-based company specializing in precision oncology, to distribute the latter’s cancer diagnostic products in Korea.Under the accord, the two companies will work to introduce Guardant Health's various liquid biopsy and tissu
Kangbuk Samsung Hospital said on Wednesday that it was selected to run the Mongolian National Diagnostic and Treatment Center Operation and Management Consulting Project organized by the Korea Foundation for International Healthcare (KOFIH).Kangbuk Samsung Hospital has conducted the first and second
Asan Medical Center (AMC), recently fined for violating the Medical Service Act due to a nurse practitioner performing a periosteal puncture to collect bone marrow tissue instead of a doctor, has filed an appeal with the Supreme Court. The hospital argued that the appeals court trial, which reversed
A team of researchers at Seoul National University Bundang Hospital (SNUBH) revealed that the risk of early-onset colorectal cancer (CRC) increased by 9 percent for moderate drinkers and by 20 percent for heavy drinkers. The team of researchers led by Professors Shin Cheol-min and Jin Eun-Hyo of the
Oncology experts celebrated the joint reimbursement of Opdivo together with its PD-L1 IHC 28-8 PharmDx companion diagnostic (CDx) platform for first-line treatment and diagnosis of advanced and metastatic gastric cancer in Korea.However, they noted diagnosis platforms need work to improve treatment
ABL Bio will likely be able to resume its U.S. phase 1 clinical trial of ABL301, a candidate for treating Parkinson's disease licensed out to Sanofi, the company said.ABL Bio said Wednesday it had confirmed the safety of ABL 301 in a nonclinical toxicity study to determine the feasibility of adminis
The Korean Society of Radiology (KSR) will host the Korean Congress of Radiology 2023 (KCR 2023), its 79th annual conference, at COEX, southern Seoul, from Sept. 20 to 23.Under the slogan “Exploring Beyond the Horizon,” the congress has attracted 499 pre-registrations from abroad. According to the s
The Korean health authorities reported the first confirmed case of a Korean patient infected with the BA.2.86 variant of Covid-19, also known as "Pirola," believed to possess a high degree of immune evasion.The Central Disease Control Headquarters (CDCH) said Wednesday that it detected the Pirola va
Samjin Pharmaceutical announced on Wednesday that Wellysis has obtained U.S. FDA approval for S-Patch Ex, a wearable electrocardiogram (ECG) monitor.S-Patch Ex has been developed by Wellysis, a digital healthcare startup that spun off from Samsung SDS in 2019. In the Korean market, Samjin Pharmaceut
As the neurofibromatosis drug Koselugo (selumetinib) faces resubmission to the Pharmaceutical Reimbursement Evaluation Committee meeting on Thursday, patients and their families called for swift insurance benefits.On Wednesday last week, the Korean Organization for Rare Diseases (KORD) filed a petit
Korean digital therapeutics (DTx) makers have not made a single license application since April, according to the regulatory agency.Noting that the Nos. 1 and 2 DTx had debuted in the domestic market, industry insiders predicted that it would likely take a considerable time for the No. 3 DTx to get
If you're a woman in your 40s or older and you're experiencing symptoms such as bloating, indigestion, and weak urine flow, one cancer you should be aware of is ovarian cancer. It's worth noting that this cancer is often diagnosed in about 50 percent of cases at stage 3 or 4.Appearing on Seoul Natio
Ybrain, a company specializing in mental health therapeutics, said on Wednesday that a clinical trial conducted in the U.S. using its depression electroceutical, MINDD STIM, showed efficacy in improving immediate depression symptoms.Depressed patients have difficulty interpreting other people's emot
The Korean Medical Association (KMA) and the Korean Hospital Association (KHA) have petitioned the Constitutional Court to review and temporarily halt the enforcement of the revised medical law, which mandates the installation of closed-circuit TV (CCTV) cameras in operating rooms from Sept. 25.The
Severance Hospital said it will launch a nationwide registry to collect clinical information on children with cerebral palsy from birth to diagnosis and treatment status in Korea.Severance Hospital unveiled its plans on Tuesday to initiate the Korean Cerebral Palsy Registry Project, aimed at enhanci
Urology experts highlighted the benefits of Boston Scientific’s Rezum system as a safe incision-less, implant-free, and local anesthesia procedure with proven efficacy compared to other procedures such as transurethral resection of the prostate (TURP).Boston Scientific held a press conference to com